# A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers

> **NCT01489306** · PHASE1 · COMPLETED · sponsor: **MicroDose Therapeutx, Inc** · enrollment: 36 (estimated)

## Conditions studied

- Drug Safety

## Interventions

- **DRUG:** MDT-637
- **DRUG:** MDT-637

## Key facts

- **NCT ID:** NCT01489306
- **Lead sponsor:** MicroDose Therapeutx, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2012-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489306, "A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01489306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*